Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $18.0000 (-3.23%) ($17.7000 - $18.8000) on Mon. Dec. 4, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.03% (three month average) | RSI | 13 | Latest Price | $18.0000(-3.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2% a day on average for past five trading days. | Weekly Trend | CAPR declines -11.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) SKYY(8%) XLF(8%) ARKK(7%) | Factors Impacting CAPR price | CAPR will decline at least -6.015% in a week (0% probabilities). GLD(-8%) GDX(-8%) TLT(-7%) SLV(-7%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.015% (StdDev 12.03%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
1 - 5 Day Possible Target | $-1.34(-107.44%) | Resistance Level | $21.57 | 5 Day Moving Average | $19.02(-5.36%) | 10 Day Moving Average | $19.91(-9.59%) | 20 Day Moving Average | $21.57(-16.55%) | To recent high | -47.8% | To recent low | 85.6% | Market Cap | $355m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |